Defence is the Best Attack: Immuno-Oncology Breakthroughs
Chris Iliffe <christopher.iliffe@eacr.org>
One of our most popular conferences, Defence is the Best Attack 2023 will be our fourth on this topic. Participants will learn about the most recent advances in immunotherapy, from the basic science to clinical studies, including the identification of novel targets. Topics to be covered immune checkpoints and innate immune response, microbioma, immune cell therapies, vaccines, and biomarkers of response to and mechanisms of resistance to immunotherapy. Alberto Montovani (Humanitas University), Tyler Jacks (MIT, USA), and Josep Tabnernero (VHIO, Spain) will give keynote speeches.
Deadlines:
Travel grant application deadline: 13 February 2023
Abstract submission deadline: 13 February 2023
Registration deadline: 13 March 2023
Keywords: oncology, molecular oncology, immuno-oncology, immune system interactions, novel therapeutic approaches to cancer, identification of novel targets, therapeutic interventions, biomarkers of immune response, mechanisms of intrinsic resistance, mechanisms of acquired resistance, chemotherapy resistance, immune checkpoints, innate immune response, microbioma, immune cell therapies, cancer vaccines, cancer research.
